Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[11C]Raclopride‐PET studies of the Huntington's disease rate of progression: Relevance of the trinucleotide repeat length

1 Feb 1998

Abstract excerpt

We used [11C]raclopride and positron emission tomography (PET) to assess the relationship between striatal dopamine D2 receptor binding, trinucleotide repeat number (CAG), and subject age in 10 asymptomatic and 8 symptomatic carriers of the Huntington's disease (HD) mutation. In both preclinical and symptomatic gene carriers, we found significant correlations between CAG repeat length and the ratio of percent...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Neurodegenerative Diseases
Share to Mitochondrial Function and Pathology
Share to Neurological disorders and treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 9485067
DOI: 10.1002/ana.410430216

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[11C]Raclopride‐PET studies of the Huntington's disease rate of progression: Relevance of the trinucleotide repeat lengthPMID 9485067Read ↗

Trinucleotide repeat length and rate of progression of Huntington's diseaseSemantic proximity Read ↗

Association of CAG Repeats With Long-term Progression in Huntington DiseaseSemantic proximity Read ↗

Trinucleotide repeat length and clinical progression in Huntington's disease.Semantic proximity Read ↗

Clinical presentation and patterns of regional cerebral atrophy related to the length of trinucleotide repeat expansion in patients with adult onset Huntington's disease.Semantic proximity Read ↗

Trinucleotide repeat length and progression of illness in Huntington's disease.Semantic proximity Read ↗

Association of CAG Repeat Length in the Huntington Gene With Cognitive Performance in Young AdultsSemantic proximity Read ↗

A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG lengthSemantic proximity Read ↗

Changes in striatal dopamine D2 receptor binding in pre-clinical Huntington's disease.Semantic proximity Read ↗

The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease.Semantic proximity Read ↗

Longitudinal analysis of regional grey matter loss in Huntington disease: effects of the length of the expanded CAG repeat.Semantic proximity Read ↗

Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease.Semantic proximity Read ↗

Relationship between CAG repeat length and brain volume in premanifest and early Huntington's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.